South Africa Mpox Cases Rise to 22 in Western Cape

PRETORIA, SOUTH AFRICA — South Africa has confirmed four new laboratory-tested infections, bringing the total number of south africa mpox cases to 22. According to an official update released by the National Department of Health, the outbreak remains concentrated primarily in the Western Cape, which currently accounts for 18 of the total confirmed cases across the country.
The remaining cases are distributed across Gauteng, which has recorded three cases, and KwaZulu-Natal, which has logged one. Epidemiological data indicates that 21 of the 22 patients are male. Recent cases highlight clear international travel links, including a 47-year-old Cape Town resident who recently returned from Spain, along with two imported cases involving German and Norwegian nationals.
Regional Distribution & Epidemiological Profile
The geographic spread and clinical profile of the current mpox cluster include:
| Geographic Province | Confirmed Cases | Epidemiological Notes |
| Western Cape | 18 Cases | Primary regional cluster with travel-related links |
| Gauteng | 3 Cases | Holds local stock of 586 mpox vaccine doses |
| KwaZulu-Natal | 1 Case | Isolated case under active contact tracing |
| Demographic Breakdown | 21 Males / 1 Female | Patterns mirror international transmission clusters |
Health Department Response to South Africa Mpox Cases
Managing the spread of south africa mpox cases relies on aggressive contact tracing and public awareness. Health Ministry spokespersons Foster Mohale and Sello Lediga advised anyone experiencing symptoms within 21 days of exposure to seek immediate care. Common symptoms include high fever, severe headaches, muscle aches, fatigue, and distinct skin lesions across affected areas.
Department officials, alongside the National Institute for Communicable Diseases (NICD) and the World Health Organization, continue monitoring potential community spread. A critical operational factor is the limited vaccine supply, with Gauteng reporting 586 available doses. Health authorities are assessing strategic dose allocation across provinces to ensure close contacts of confirmed cases and high-risk groups receive targeted immunization to halt further transmission.
Why It Matters: Determining whether new cases are traced contacts or unlinked infections will reveal if South Africa’s contact tracing is successfully containing the cluster.
Source: South African Government, September 2026



